{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-21-000008","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.296053+00:00","generated_at":"2026-06-28T09:02:29.729411+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rapid Micro Biosystems Q3 commercial revenue $6.3M (+27%); reaffirms FY21 outlook","bullets":["Commercial revenue $6.3M (+27% YoY); recurring commercial revenue $2.2M (+154% YoY).","Net loss of $25.0M includes $8.2M warrant fair-value adjustment and $3.1M debt-repayment charge.","Cash $220M, no debt; repaid $28.7M term debt in September using IPO proceeds.","Placed 10 Growth Direct systems and completed validation of 5 customer systems in Q3.","Reaffirms FY2021 commercial revenue outlook of at least $24M, representing ≥70% YoY growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-21-000008","json":"https://secwatch.observer/filing/0001380106-21-000008.json","markdown":"https://secwatch.observer/filing/0001380106-21-000008.md","text":"https://secwatch.observer/filing/0001380106-21-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010621000008/0001380106-21-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010621000008/rpid-20211111x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:02:29.729411+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}